Nobuhisa Ishikawa

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.

Yusuke Nakamura, Eiju Tsuchiya, Tatsuya Kato, 2005, Cancer research.

Airflow limitation in smokers is associated with subclinical atherosclerosis.

Hitoshi Hara, Yoshihiro Kitahara, Hiroshi Iwamoto, 2009, American journal of respiratory and critical care medicine.

Development of Serum Glycoproteomic Profiling Technique; Simultaneous Identification of Glycosylation Sites and Site-Specific Quantification of Glycan Structure Changes*

Yusuke Nakamura, Naomi Saichi, Hidewaki Nakagawa, 2010, Molecular & Cellular Proteomics.

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

Yusuke Nakamura, Tatsuhiko Tsunoda, Takashi Tsuruo, 2004, Human molecular genetics.

Levels of Surfactant Proteins A and D and KL-6 Are Elevated in the Induced Sputum of Chronic Obstructive Pulmonary Disease Patients: A Sequential Sputum Analysis

N. Kohno, A. Yokoyama, V. Kinnula, 2011, Respiration.

Characterization of SEZ6L2 cell‐surface protein as a novel prognostic marker for lung cancer

Yusuke Nakamura, Eiju Tsuchiya, Atsushi Takano, 2006, Cancer science.

Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer

Yusuke Nakamura, Eiju Tsuchiya, Tatsuya Kato, 2007, Molecular Cancer Therapeutics.

A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.

Yusuke Nakamura, Satoshi Kondo, Tatsuya Kato, 2005, Cancer research.

The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.

Yusuke Nakamura, Eiju Tsuchiya, Atsushi Takano, 2006, Cancer research.